23 research outputs found

    Characterizing a Common Class of Spontaneous Movements

    No full text
    Our aim is to describe a possible class of nonpathological spontaneous movements that has so far received little attention in the scientific literature. These movements arise spontaneously without an underlying pathology such as Huntington’s, Parkinson’s, cerebral palsy or spinal cord injury. The movements arise in many different contexts including therapeutic, social, religious, and solitary settings. Anecdotal evidence suggests that the movements are related to development and maintenance of form, being part of inherited autoregulatory behaviors and hence bringing an overlooked therapeutic potential. We describe contexts in which they occur, illustrate with case reports, and characterize the movements in terms of their various triggers, movement phenotypes, and conscious and subconscious influences that can occur at both the individual level as well as during collaborative movement relationships between patient and therapist. This description is intended to create a more widespread awareness of the movements, and provide a foundation for future research as to their healing potential

    LesĂ”es traumĂĄticas do parĂȘnquima pulmonar: aspectos na tomografia computadorizada Traumatic lung lesions: computed tomography findings

    No full text
    As lesĂ”es pulmonares sĂŁo achados freqĂŒentes no trauma torĂĄcico, sendo cada vez mais diagnosticadas pela tomografia computadorizada, em especial pelo rĂĄpido tempo de aquisição decorrente da tĂ©cnica helicoidal, que permite a avaliação de pacientes em estado grave, possibilitando a adoção de conduta terapĂȘutica eficiente. Os autores estudaram 150 pacientes vĂ­timas de trauma torĂĄcico submetidos a tomografia computadorizada, que apresentaram lesĂ”es pulmonares, representadas por contusĂ”es, atelectasias, laceraçÔes e hematomas pulmonares. As contusĂ”es pulmonares se caracterizaram por consolidaçÔes e atenuação em vidro fosco, sendo as lesĂ”es pulmonares mais comuns. As atelectasias foram observadas com os padrĂ”es subsegmentar e compressiva, e foram a segunda lesĂŁo mais comum. As laceraçÔes se apresentaram como consolidaçÔes com ar ou nĂ­vel lĂ­quido no interior. Os hematomas pulmonares representaram a lesĂŁo pulmonar mais rara, presentes em apenas cinco casos, caracterizados por opacidades arredondadas. Neste trabalho o trauma torĂĄcico fechado predominou, com 120 casos, enquanto o trauma aberto ocorreu em 30 casos. As causas de trauma fechado, em ordem decrescente de freqĂŒĂȘncia, foram: colisĂŁo automobilĂ­stica, atropelamento, queda de altura, acidente de motocicleta e espancamento. A forma penetrante de traumatismo torĂĄcico decorreu de duas causas de agressĂŁo: lesĂŁo por arma de fogo e lesĂŁo por arma branca.<br>Traumatic lesions of the lung are common findings in patients with thoracic trauma. These lesions are increasingly diagnosed using computed tomography, mostly due to the fast acquisition time helical techniques that allow evaluation of critically ill patients and an efficient therapeutic management. The authors studied 150 patients with thoracic trauma submitted to computed tomography that demonstrated lung contusions, atelectasies, lacerations and hematomas. Lung contusions were the most frequent lesions appearing as consolidation or ground-glass attenuation areas. Atelectasies, in subsegmentar and compressive patterns, were the second most common lesions observed. Lacerations appeared as consolidations with air or liquid level. Lung hematomas, characterized by round opacities, were the most rare lung lesions seen in only five cases. In this study, blunt thoracic trauma accounted for the majority of 120 cases whereas penetrating trauma occurred in 30 cases. The causes of blunt trauma in decrescent order of frequency were motor vehicle accidents, pedestrian hit by car, falls, motorcycle accidents and trashing. Penetrating traumas were caused by bullets or knives

    Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial

    No full text
    BACKGROUND: Low-dose oral vitamin K decreases the international normalized ratio (INR) in overanticoagulated patients who receive warfarin therapy. Its effects on bleeding events are uncertain. OBJECTIVE: To see whether low-dose oral vitamin K reduces bleeding events over 90 days in patients with warfarin-associated coagulopathy. DESIGN: Multicenter, randomized, placebo-controlled trial. Randomization was computer-generated, and participants were allocated to trial groups by using sequentially numbered study drug containers. Patients, caregivers, and those who assessed outcomes were blinded to treatment assignment. SETTING: 14 anticoagulant therapy clinics in Canada, the United States, and Italy. PATIENTS: Nonbleeding patients with INR values of 4.5 to 10.0. INTERVENTION: Oral vitamin K, 1.25 mg (355 patients randomly assigned; 347 analyzed), or matching placebo (369 patients randomly assigned; 365 analyzed). MEASUREMENTS: Bleeding events (primary outcome), thromboembolism, and death (secondary outcomes). RESULTS: 56 patients (15.8%) in the vitamin K group and 60 patients (16.3%) in the placebo group had at least 1 bleeding complication (absolute difference, -0.5 percentage point [95% CI, -6.1 to 5.1 percentage points]); major bleeding events occurred in 9 patients (2.5%) in the vitamin K group and 4 patients (1.1%) in the placebo group (absolute difference, 1.5 percentage points [CI, -0.8 to 3.7 percentage points]). Thromboembolism occurred in 4 patients (1.1%) in the vitamin K group and 3 patients (0.8%) in the placebo group (absolute difference, 0.3 percentage point [CI, -1.4 to 2.0 percentage points]). Other adverse effects were not assessed. The day after treatment, the INR had decreased by a mean of 1.4 in the placebo group and 2.8 in the vitamin K group (P < 0.001). Limitation: Patients who were actively bleeding were not included, and warfarin dosing after enrollment was not mandated or followed. CONCLUSION: Low-dose oral vitamin K did not reduce bleeding in warfarin recipients with INRs of 4.5 to 10.0. Funding: Canadian Institutes of Health Research and Italian Ministry of Universities and Researc
    corecore